NCT07684677

Brief Summary

Pregnancy loss is the most common severe pregnancy complication and is associated with significant mental health sequelae, including depression and anxiety. Standard care in Denmark does not include systematic follow-up or aetiological investigation after pregnancy loss. The Copenhagen Odense Pregnancy Loss (COPL) Cohort offered extensive aetiological investigations, and a dedicated clinical follow-up visit 4-10 weeks post-loss. This is a target trial emulation (TTE) designed to estimate the causal effect of COPL participation on women's mental health outcomes one year after pregnancy loss. We will emulate a target trial comparing (1) enrolment into COPL versus (2) standard pregnancy loss care. The study population comprises women aged ≥18 years with a confirmed intrauterine pregnancy loss (ICD-10: DO020, DO021, DO030-DO034) before 22 weeks' gestation treated at Danish public hospitals between November 2020 and April 2025. The primary outcome is new-onset affective disorder (ICD-10: F32\*-F39\*), neurotic/stress-related disorder (F41\*, F43\*, F48\*), or dispensing of antidepressant (N06A\*), anxiolytic (N05B\*), or sedating (N05C\*) medication within 12 months of pregnancy loss diagnosis. All data will be sourced from Danish National Registries. The difference-in-differences estimator will serve as the primary analytical approach, complemented by instrumental variable analysis (hospital of treatment as instrument) and regression discontinuity design. Inverse probability of treatment weighting will be used to control for measured confounders. Results will be reported as risk ratios and risk differences with 95% confidence intervals. Sensitivity analyses will include per-protocol estimation and exclusion of women with treatable findings identified in COPL.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30,000

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Nov 2020Apr 2027

Study Start

First participant enrolled

November 1, 2020

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2025

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2027

Expected
Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

4.4 years

First QC Date

June 29, 2026

Last Update Submit

June 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • New onset affective or stress-related disorder

    Either ICD-10 F32\*-F39\*, F41\*, F43\*, F48\* registered or prescription of antidepressant, anxiolytic or sedating medication after PL

    12 months after PL

Secondary Outcomes (4)

  • Sick leave

    First 12 months after PL

  • Health care utilization

    12 months after PL

  • Time to pregnancy

    Up to 12 months

  • Post-natal mood disorder

    Up to 12 months after time zero

Study Arms (2)

COPL participant

EXPERIMENTAL

Women with pregnancy loss participating in the COPL Cohort

Other: COPL participation

Controls

NO INTERVENTION

Women not included in the COPL cohort

Interventions

Participation in the COPL cohort

COPL participant

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 18 years
  • Born in Denmark
  • Verified intrauterine PL before 22 weeks' gestation treated at a public hospital in Denmark

You may not qualify if:

  • Non-visualized PL, ectopic PL
  • Gestational age \>22 weeks at loss

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gynecology-and-Obstetrics

Hvidovre, Denmark

Location

MeSH Terms

Conditions

Abortion, SpontaneousDepressive Disorder, MajorAnxiety Disorders

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Henriette Svarre Nielsen, Professor

    Copenhagen University Hospital, Hvidovre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Target trial emulation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor, Associate professor

Study Record Dates

First Submitted

June 29, 2026

First Posted

July 6, 2026

Study Start

November 1, 2020

Primary Completion

April 11, 2025

Study Completion (Estimated)

April 11, 2027

Last Updated

July 6, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

It is not permitted

Locations